Back
AstraZeneca PLC Quote, Financials, Valuation and Earnings
Buy
70
AZNCF
AstraZeneca PLC
Last Price:
154.61
Seasonality Move:
3.63%
7 Day Trial
ALL ACCESS PASS
$
7
AstraZeneca PLC Price Quote
$154.61
AstraZeneca PLC Key Stats
Buy
70
AstraZeneca PLC (AZNCF)
is a Buy
Day range:
$153.02 - $154.61
52-week range:
$118.16 - $159.12
Dividend yield:
1.87%
P/E ratio:
40.58
P/S ratio:
5.07
P/B ratio:
6.4%
Volume:
445
Avg. volume:
5.2K
1-year change:
2.42%
Market cap:
$239.7B
Revenue:
$45.8B
EPS:
$4.07
How Much Does AstraZeneca PLC Make?
-
How Much Are AstraZeneca PLC's Sales Annually?
AZNCF Revenues are $45.8B -
How Much Profit Does AstraZeneca PLC's Make A Year?
AZNCF net income is $6B
Is AstraZeneca PLC Growing As A Company?
-
What Is AstraZeneca PLC's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.17% -
What Is AstraZeneca PLC's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.21%
AstraZeneca PLC Stock Price Performance
-
Did AstraZeneca PLC Stock Go Up Last Month?
AstraZeneca PLC share price went up by 13.52% last month -
Did AZNCF's Share Price Rise Over The Last Year?
AZNCF share price rose by 2.42% over the past 1 year
What Is AstraZeneca PLC 52-Week High & Low?
-
What Is AstraZeneca PLC’s 52-Week High Share Price?
AstraZeneca PLC has traded as high as $159.12 over the past 52 weeks -
What Is AstraZeneca PLC’s 52-Week Low Share Price?
AstraZeneca PLC has traded as low as $118.16 over the past 52 weeks
AstraZeneca PLC Price To Free Cash Flow
-
Is AstraZeneca PLC Stock Overvalued?
AstraZeneca PLC is trading at a price to free cash flow ratio of 41.75 -
Is AstraZeneca PLC Stock Undervalued?
AstraZeneca PLC EV to Free Cash Flow ratio is 45.81 -
What Is AstraZeneca PLC’s Price Earnings Growth Ratio?
AZNCF PEG ratio is 1.09 -
Is AstraZeneca PLC Trading At A Premium To Earnings?
AstraZeneca PLC EV to EBIT ratio is 29.18
Is It Risky To Buy AstraZeneca PLC?
-
How Much Debt Does AstraZeneca PLC Have?
Total long term debt quarterly is $33.3B -
How Much Cash Does AstraZeneca PLC Have?
Cash and short term investments quarterly total is $8B -
What Is AstraZeneca PLC’s Book Value Per Share?
Book value per share is 24.15
Is AstraZeneca PLC Cash Flow Positive?
-
What Is AZNCF Cash Flow From Operations?
Cash flow from operations (TTM) is $9.7B -
What Is AstraZeneca PLC’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$2.5B -
What Is AstraZeneca PLC’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$5.2B
AstraZeneca PLC Return On Invested Capital
-
Is Management Doing A Good Job?
AZNCF return on invested capital is 9.45% -
What Is AstraZeneca PLC Return On Assets?
ROA measures how assets are converting to revenues and is 6.42% -
What Is AZNCF Return On Equity?
ROE is a measure of profitability and is 16.92%
AstraZeneca PLC Earnings Date & Stock Price
-
What Is AstraZeneca PLC's Stock Price Today?
A single share of AZNCF can be purchased today for 154.61 -
What Is AstraZeneca PLC’s Stock Symbol?
AstraZeneca PLC trades on the otcm under the ticker symbol: AZNCF -
When Is AstraZeneca PLC’s Next Earnings Date?
The next quarterly earnings date for AstraZeneca PLC is scheduled on May 21, 2024 -
When Is AZNCF's next ex-dividend date?
AstraZeneca PLC's next ex-dividend date is February 22, 2024 -
How To Buy AstraZeneca PLC Stock?
You can buy AstraZeneca PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
AstraZeneca PLC Competitors
-
Who Are AstraZeneca PLC's Competitors?
Below is a list of companies who compete with AstraZeneca PLC or are related in some way:
AstraZeneca PLC Dividend Yield
-
What Is AZNCF Dividend Yield?
AstraZeneca PLC’s dividend yield currently is 1.87% -
What Is AstraZeneca PLC’s Payout Ratio?
AstraZeneca PLC’s payout ratio is 70.56% -
When Did AstraZeneca PLC Last Pay A Dividend?
The latest dividend pay date is May 21, 2024 -
What Is AstraZeneca PLC’s Dividend Per Share?
AstraZeneca PLC pays a dividend of $1.97 per share
AstraZeneca PLC Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 20.69% | 0% |
Revenue: | 16.55% | 7.34% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 0.00 |
Downside from Last Price: | -100% |